Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies against APRIL as biomarkers for early prognosis of lymphoma patients

Antibodies against APRIL as biomarkers for early prognosis of lymphoma patients

US Patent 8609821 · Granted Dec 17, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the p2020
Pharmaceutical compositions and their use for the treatment of autoimmune disord2019
Method for the treatment of acne by administering IL-1β antibody2017
Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors2015
Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors2013
Nucleic acid encoding fused2013
Assay methods for suppressor of fused modulation of hedgehog signaling2009
Anti-fused antibodies2007
Nucleic acid encoding human suppressor of fused2006
Soluble polypeptide fractions of the LAG-3 protein, production method, therapeut2003
Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants2002
Fused polypeptides2002